Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System

NCT: NCT03620942 · ACTIVE_NOT_RECRUITING

NCT IDNCT03620942
StatusACTIVE_NOT_RECRUITING
Start Date2018-11-07
Completion2027-12-31
SponsorKK Women's and Children's Hospital (OTHER_GOV)
First posted
Last updated

Brief Summary

Maternal hypotension during spinal anaesthesia for Caesarean delivery may bring various adverse effects. It is therefore important to closely monitor hypotension during spinal anaesthesia, however current technology does not allow the blood pressure monitoring to respond in timely manner should there be any occurrence of hypotension. The investigators developed an advanced double-intravenous vasopressor automated system (ADIVA) so as to tackle this issue via novel algorithm to control blood pressure more rigorously with more stable haemodynamic profiles.

Frequently Asked Questions

What is Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System?

Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System is a clinical trial registered under NCT03620942. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03620942?

The current status of NCT03620942 (Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System) is: ACTIVE_NOT_RECRUITING.

When did Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System start?

Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System started on 2018-11-07.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.